Trials / Conditions / Long QT Syndrome Type 3
Long QT Syndrome Type 3
3 registered clinical trials studyying Long QT Syndrome Type 3 — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With NCT07075445 | Thryv Therapeutics, Inc. | — |
| Terminated | Effect of Eleclazine on Shortening of the QT Interval, Safety, and Tolerability in Adults With Long QT Syndrom NCT02300558 | Gilead Sciences | Phase 3 |
| Unknown | Long Term Prophylactic Therapy of Congenital Long QT Syndrome Type III (LQT3) With Ranolazine NCT01728025 | Tel-Aviv Sourasky Medical Center | Phase 2 |